Trial Profile
A Phase IIB Study to Evaluate the Effects of Welchol (Colesevelam Hydrochloride) on Colonic Transit, Intestinal Permeability and Bowel Function in Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS).
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Colesevelam (Primary)
- Indications Irritable bowel syndrome
- Focus Therapeutic Use
- 14 Mar 2012 Additional lead trial centre identified as reported by ClinicalTrials.gov.
- 26 Oct 2009 Results presented at the 74th Annual Scientific Meeting of the American College of Gastroenterology.
- 17 Jun 2009 New trial record